Please use this identifier to cite or link to this item:
Title: Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF
Austin Authors: Charidimou, Andreas;Karayiannis, Christopher;Song, Tae-Jin;Orken, Dilek Necioglu;Thijs, Vincent;Lemmens, Robin;Kim, Jinkwon;Goh, Su Mei;Phan, Thanh G;Soufan, Cathy;Chandra, Ronil V;Slater, Lee-Anne;Haji, Shamir;Mok, Vincent;Horstmann, Solveig;Leung, Kam Tat;Kawamura, Yuichiro;Sato, Nobuyuki;Hasebe, Naoyuki;Saito, Tsukasa;Wong, Lawrence KS;Soo, Yannie;Veltkamp, Roland;Flemming, Kelly D;Imaizumi, Toshio;Srikanth, Velandai;Heo, Ji Hoe;International META-MICROBLEEDS Initiative
Affiliation: J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
Harvard Medical School, Boston, MA, USA
META-MICROBLEEDS Initiative/Consortium, Boston, MA, USA
Stroke and Ageing Research Centre, Department of Medicine, School for Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
Sisli Hamidiye Etfal Education and Research Hospital, Department of Neurology, Istanbul, Turkey
Department of Neurology, Austin Health and Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
Department of Neurology, CHA Bundang Medical Centre, CHA University, Seongnam, Korea
Stroke Unit, Neurosciences, Monash Imaging, Monash Health, Melbourne, Victoria, Australia
Neuroradiology Service, Monash Imaging, Monash Health, Melbourne, Victoria, Australia
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong
Department of Neurology, University of Heidelberg, Germany
Department of Internal Medicine, Cardiovascular, Respiratory and Neurology Division, Asahikawa Medical University, Japan
Department of Stroke Medicine, Division of Brain Sciences, Imperial College London, UK
Department of Neurosurgery, Kushiro City General Hospital, Hokkaido, Japan
KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease, Belgium
VIB, Vesalius Research Center, Laboratory of Neurobiology, Belgium
University Hospitals Leuven, Department of Neurology, Belgium
Department of Neurology, College of Medicine, Ewha Woman's University, Yangcheon-gu, Seoul, Korea
Issue Date: 5-Dec-2017 2017-12-05
Publication information: Neurology 2017; 58(23): 2317-2326
Abstract: OBJECTIVES: To assess the association between cerebral microbleeds (CMBs) and future spontaneous intracerebral hemorrhage (ICH) risk in ischemic stroke patients with nonvalvular atrial fibrillation (AF) taking oral anticoagulants. METHODS: This was a meta-analysis of cohort studies with >50 patients with recent ischemic stroke and documented AF, brain MRI at baseline, long-term oral anticoagulation treatment, and ≥6 months of follow-up. Authors provided summary-level data on stroke outcomes stratified by CMB status. We estimated pooled annualized ICH and ischemic stroke rates from Poisson regression. We calculated odds ratios (ORs) of ICH by CMB presence/absence, ≥5 CMBs, and CMB topography (strictly lobar, mixed, and strictly deep) using random-effects models. RESULTS: We established an international collaboration and pooled data from 8 centers including 1,552 patients. The crude CMB prevalence was 30% and 7% for ≥5 CMBs. Baseline CMB presence (vs no CMB) was associated with ICH during follow-up (OR 2.68, 95% confidence interval [CI] 1.19-6.01, p = 0.017). Presence of ≥5 CMB was related to higher future ICH risk (OR 5.50, 95% CI 2.07-14.66, p = 0.001). The pooled annual ICH incidence increased from 0.30% (95% CI 0.04-0.55) among CMB-negative patients to 0.81% (95% CI 0.17-1.45) in CMB-positive patients (p = 0.01) and 2.48% (95% CI 1.2-6.2) in patients with ≥5 CMBs (p = 0.001). There was no association between CMBs and recurrent ischemic stroke. CONCLUSIONS: The presence of CMB on MRI and the dichotomized cutoff of ≥5 CMBs might identify subgroups of ischemic stroke patients with AF with high ICH risk and after further validation could help in risk stratification, in anticoagulation decisions, and in guiding randomized trials and ongoing large observational studies.
DOI: 10.1212/WNL.0000000000004704
ORCID: 0000-0002-6614-8417
Journal: Neurology
PubMed URL:
Type: Journal Article
Subjects: Anticoagulants
Atrial Fibrillation
Cerebral Hemorrhage
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jan 27, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.